Nagpur, Maharashtra
GST No. 27AMPPS8870F1Z9
Call 08048989600
Send Enquiry
WE ARE WELL KNOWN PHARMA DISTRIBUTOR AND DROP SHIPPER BASED IN INDIA, MANAGED BY SKILLED PROFESSIONALS WITH VAST EXPERIENCE AND WE PROVIDE FULL SERVICE EXPORT AND DROP SHIPPING PROVIDER FOR PHARMACEUTICAL PRODUCTS FROM INDIA TO OUR CLIENTS THROUGHOUT THE GLOBE . OUR MOTTO IS SUPPLY HIGH QUALITY DRUGS @ LOW PRICES.
Minimum Order Quantity: 10 Strip
| Strength | 1000 mg |
| Packaging Type | Stripe |
| Packaging Size | 5x3 |
| Brand | Valcivir 1000 Mg Tablets |
| Manufacturer | Cipla Ltd |
Generic Name: Valacyclovir Hydrochloride
Brand Name: Valcivir
Strength: 1000 mg
Manufacturer: Cipla Ltd
Drug Class: Antiviral (Nucleoside analogue)
Each tablet contains:
Valacyclovir Hydrochloride 1000 mg (prodrug of acyclovir)
Valcivir 1000 mg is prescribed for:
Herpes Zoster (Shingles)
Genital Herpes (initial & recurrent episodes)
Cold Sores (Herpes Labialis)
Suppression of recurrent genital herpes
Reduction of transmission of genital herpes
Cytomegalovirus (CMV) prophylaxis in transplant patients
Chickenpox (in immunocompromised adults in some cases)
Valacyclovir is rapidly converted to Acyclovir in the body. Acyclovir acts by:
Inhibiting viral DNA polymerase
Incorporating into viral DNA and terminating its synthesis
This stops the replication of herpes viruses.
Shingles (Herpes Zoster): 1000 mg 3 times daily for 7 days
Genital Herpes (initial): 1000 mg twice daily for 7–10 days
Recurrent episodes: 500 mg twice daily for 3 days
Suppression: 500–1000 mg once daily
CMV Prophylaxis: 2000 mg 4 times daily (adjusted by condition)
Note: Dose adjustment needed in renal impairment
��️ Shelf Life: 24–36 months �� Storage: Store below 30°C, protect from moisture �� Key Points:Valcivir is more bioavailable than plain acyclovir → requires less frequent dosing
Used early in the outbreak for better results
Effective in reducing viral shedding and transmission risk in long-term use
Additional Information:
View Complete details
| SKU | mm44 |
|---|---|
| Best_Value | No |
| US Brand Name | Retin A Cream |
| Strength | .025% (20gm) |
| Generic Name | Tretinoin |
| Pharmaceutical Form | Tube/s |
| Per Unit Pharmaceutical Form | Tube |
| Manufacturer | Johnson & Johnson, India |
| Shipped From | India |
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 300 mg |
| Manufactured By | Emcure Pharma |
| Brand | Emcure |
| Form | Capsule |
| Country of Origin | Made in India |
Generic Name: Atazanavir 200 mg
Manufacturer: Emcure Pharmaceuticals Ltd
Drug Class: Protease Inhibitor (Antiretroviral)
Indication:
Used in the treatment of HIV-1 infection, typically in combination with other antiretroviral agents.
Helps reduce the viral load and boost immune function.
Mechanism of Action:
Inhibits the HIV-1 protease enzyme, which is essential for viral replication. Prevents cleavage of gag-pol polyproteins, resulting in immature, noninfectious virus particles.
Dosage & Use:
Typically given as two 200 mg capsules once daily with Ritonavir 100 mg.
Must be taken with food to improve absorption.
Side Effects:
Jaundice, nausea, hyperbilirubinemia, rash, abdominal pain, lipid changes.
Shelf Life:
Usually 24 months from the date of manufacture.
Generic Name: Atazanavir 300 mg
Manufacturer: Emcure Pharmaceuticals Ltd
Drug Class: Protease Inhibitor (Antiretroviral)
Indication:
First-line and widely used drug for HIV-1 treatment in combination with Ritonavir or Cobicistat, and a dual NRTI backbone.
Mechanism of Action:
Same as above – inhibits HIV protease, blocking viral replication.
Dosage & Use:
One capsule (300 mg) once daily with Ritonavir 100 mg, along with other antiretrovirals.
Must be taken with food.
Side Effects:
Similar to 200 mg, with more pronounced bilirubin elevation in some patients due to higher plasma concentrations.
Shelf Life:
Also 24 months from manufacture date.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 300 mg / 100 mg |
| Composition | ATAZANAVIR & RITONAVIR |
| Packaging Size | 30 Tablets |
| Brand | Atazor-R Tablets Ip |
| Country of Origin | Made in India |
Manufacturer: Emcure Pharmaceuticals
Composition:
Atazanavir 300 mg
Ritonavir 100 mg
Description:
Atazor-R is a fixed-dose combination of two antiretroviral agents:
Atazanavir, a protease inhibitor, suppresses HIV replication by inhibiting the viral protease enzyme.
Ritonavir acts as a pharmacokinetic enhancer, increasing the effectiveness of atazanavir by inhibiting its metabolism.
Indication:
Used in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and adolescents.
Dosage:
Usually once daily with food, as prescribed by a healthcare provider.
Shelf Life:
24 months from the date of manufacture.
Manufacturer: Hetero Healthcare
Composition:
Atazanavir 300 mg
Ritonavir 100 mg
Description:
Hiataz-R is another fixed-dose combination antiretroviral therapy. It contains the same active ingredients as Atazor-R and works similarly:
Suppresses the HIV viral load.
Increases CD4 cell count.
Slows disease progression when used as part of a triple-drug regimen.
Indication:
Approved for the management of HIV-1 infection in combination therapy.
Dosage:
Typically once daily with food.
Shelf Life:
24 months from manufacturing.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 600 mg |
| Pack Size | 1*60 Tablet |
| Brand Name | Virem 600 mg |
| Manufacturer | Emcure Pharma |
| Usages | HIV Treatment |
| Country of Origin | Made in India |
Manufacturer: Emcure Pharmaceuticals
Generic Name: Efavirenz 600 mg
Virem 600 mg contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Efavirenz works by inhibiting reverse transcriptase, an enzyme crucial for the replication of the HIV virus. By doing so, it helps reduce the viral load and increase CD4 cell count, thereby improving immune function.
✅ Indications:Part of highly active antiretroviral therapy (HAART) for:
HIV-1 infection in adults and children (≥3 years or ≥10 kg)
Post-exposure prophylaxis (PEP) in some regimens when combined appropriately
600 mg once daily, preferably at bedtime to minimize CNS side effects
Should be taken on an empty stomach (food increases risk of side effects, especially CNS-related)
May cause dizziness, insomnia, vivid dreams, or confusion – typically resolves over time
Use caution in patients with psychiatric history or liver impairment
Avoid alcohol and drugs that may increase CNS effects
Not recommended during pregnancy, unless no alternative available (older concern due to potential teratogenicity)
24 months from date of manufacture
Store at room temperature, away from moisture and heat
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 600 mg / 100 mg |
| Packaging Type | Bottle |
| Packaging Size | 60 tablets |
| Brand | Virem R Tablets |
| Manufacturer | Emcure Pharma |
| Country of Origin | Made in India |
Composition: Darunavir 800 mg + Ritonavir 100 mg
Category: Protease inhibitor combination
Usage:
Used in second-line HIV treatment
Prescribed when patients are resistant to first-line antiretrovirals
Mechanism:
Darunavir inhibits the HIV protease enzyme, preventing viral replication.
Ritonavir boosts Darunavir's levels by slowing its metabolism.
Dosage: Once daily (usually with food)
Common Side Effects: Rash, nausea, abdominal pain, diarrhea, lipid elevation
Special Note: Must be used in combination with other antiretroviral agents.
Composition: Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg
Category: Fixed-dose combination antiretroviral therapy
Usage:
First-line treatment of HIV-1 infection in adults and adolescents
Aligns with WHO-recommended regimen
Mechanism:
Tenofovir & Lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs)
Dolutegravir is an integrase strand transfer inhibitor (INSTI)
Dosage: Once daily
Common Side Effects: Headache, insomnia, nausea, fatigue, dizziness
Advantages: High barrier to resistance, well-tolerated
Composition: Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg + Ritonavir-boosted Dolutegravir 50 mg (or Dolutegravir alone depending on formulation)
Category: Triple-drug combination ART
Usage:
Widely used for first-line ART in adults and adolescents
Suitable for treatment-naïve patients
Mechanism:
Same as Nuace: Combines NRTIs and INSTI for potent viral suppression.
Dosage: Once daily
Common Side Effects: Similar to Nuace
Advantages:
Preferred in national HIV treatment programs
Effective against resistant strains (Dolutegravir’s benefit)
Cost-effective and WHO-aligned
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Dose Strength | 50 mg |
| Packaging Size | 30 tablets |
| Manufacture By | Emcure Pharma |
| Packaging Type | Bottle |
| Brand | Instgra 50 Mg |
Generic Name: Dolutegravir 50 mg
Manufacturer: Emcure Pharmaceuticals
📌 Description:
Xapavir is an antiretroviral medication containing Dolutegravir, an integrase strand transfer inhibitor (INSTI) used in the treatment of HIV-1 infection. It works by blocking the HIV integrase enzyme, which is essential for viral replication.
🧪 Composition:
Dolutegravir Sodium equivalent to Dolutegravir 50 mg
💡 Uses:
HIV-1 infection (usually in combination with other antiretrovirals)
📆 Dosage:
Typically once daily, as advised by a physician
May be used once or twice daily depending on previous ART history and resistance profile
⚠️ Side Effects:
Insomnia
Headache
Nausea
Diarrhea
Rarely, liver enzyme elevation
Generic Name: Dolutegravir 50 mg
Manufacturer: Hetero Healthcare
📌 Description:
Instgra is a generic form of Dolutegravir, a potent HIV integrase inhibitor. It helps reduce the amount of virus in the body, keeping the immune system strong and lowering the chances of developing HIV-related complications.
🧪 Composition:
Dolutegravir Sodium equivalent to Dolutegravir 50 mg
💡 Uses:
Used in combination ART regimens for the management of HIV-1
📆 Dosage:
Typically once daily, can be adjusted based on ART regimen
⚠️ Side Effects:
Fatigue
Depression (rare)
Rash
Gastrointestinal disturbances
✅ Note:
Instgra is widely prescribed due to its high genetic barrier to resistance and convenient dosing.
Generic Name: Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg + Dolutegravir 50 mg
Manufacturer: Mylan (Viatris)
📌 Description:
Myltega is a once-daily fixed-dose combination tablet containing three antiretroviral agents:
Dolutegravir (INSTI)
Emtricitabine (NRTI)
Tenofovir Alafenamide (NRTI)
This combo provides complete HIV-1 therapy in a single pill, improving adherence.
🧪 Composition:
Dolutegravir 50 mg
Emtricitabine 200 mg
Tenofovir Alafenamide (TAF) 25 mg
💡 Uses:
First-line treatment of HIV-1 infection in adults and adolescents
📆 Dosage:
One tablet once daily with or without food
⚠️ Side Effects:
Headache
Nausea
Fatigue
Insomnia
Possible weight gain with long-term use
✅ Advantages:
Single-pill regimen
Low renal and bone toxicity (due to TAF over TDF)
High potency with minimal resistance
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 600 mg |
| Brand | Efavir 600 Mg |
| Manufacturer | Cipla Ltd |
| Composition | Efavirenz Tablets IP |
| Packaging Size | 30 tablets |
| Country of Origin | Made in India |
Generic Name: Efavirenz 600 mg
Manufacturer: Cipla Ltd
📌 Description:
Efavir 600 mg is a single-drug non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection, commonly prescribed as part of a triple drug regimen.
Efavirenz works by blocking the reverse transcriptase enzyme, thereby preventing the virus from multiplying in the body.
It is commonly found in fixed-dose combinations such as TLE (Tenofovir + Lamivudine + Efavirenz).
🧪 Composition:
Efavirenz 600 mg
💡 Indication / Uses:
Treatment of HIV-1 infection in adults and adolescents
Often used as part of first-line therapy (especially prior to Dolutegravir-based regimens)
📆 Dosage:
One tablet daily, usually at bedtime (to minimize central nervous system side effects)
Often taken with other ARVs like Tenofovir and Lamivudine
✅ Benefits:
Long-standing usage with well-established efficacy
Once-daily dosing
Cost-effective
Still in use in many national HIV programs (especially where Dolutegravir isn’t available)
🗓️ Shelf Life:
24 months from date of manufacture
Store below 30°C, in original packaging away from moisture
Generic Name: Efavirenz 200 mg
Manufacturer: Emcure Pharmaceuticals Ltd
📌 Description:
Efcure 200 mg is a lower-strength Efavirenz formulation, primarily used in pediatric HIV treatment or for dose adjustment in adults when 600 mg tablets are not preferred.
It works via the same mechanism — blocking HIV reverse transcriptase and preventing viral replication.
It may be used as 3 capsules once daily in adults if 600 mg tablets are unavailable.
🧪 Composition:
Efavirenz 200 mg
💡 Indication / Uses:
Pediatric HIV-1 therapy (dose adjusted by weight)
Adults requiring dose-splitting or gradual titration
Useful in combination regimens where separate drug control is needed
📆 Dosage:
Adults: 3 capsules once daily = 600 mg
Children: Dosing by weight (e.g., 10–20 mg/kg/day)
Always under supervision of a healthcare provider
✅ Benefits:
Flexibility in dose customization
Preferred in pediatrics
Available for programs focusing on children's HIV treatment
🗓️ Shelf Life:
24 months
Store below 30°C, keep dry
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 30 mg |
| Packing Type | Bottle |
| Packaging Size | 60 Tablets |
| Brand | Emduo 30 mg Kit |
| Manufacturer | Emcure Pharma |
| Shelf Life | 24 months |
Manufacturer: Mylan Pharmaceuticals (a Viatris company)
Drug Class: Antiretroviral combination kit
Used For: HIV-1 Infection
Each Emduo Kit 30 mg typically contains a daily combination of the following 2 tablets (commonly packed together):
Efavirenz 600 mg tablet
Lamivudine 300 mg + Tenofovir Disoproxil Fumarate (TDF) 300 mg tablet
🔹 Total Daily Dose:
Efavirenz 600 mg
Lamivudine 300 mg
Tenofovir DF 300 mg
⚠️ This is equivalent to a TLE regimen, but provided as 2 separate pills per day (not a single fixed-dose combination tablet).
📌 Description:Emduo Kit 30 mg is used for the once-daily treatment of HIV-1 infection in adults and adolescents. It combines three antiretroviral agents that work together to suppress the replication of the virus in the body.
This kit format is useful in areas where fixed-dose combinations like TLE are unavailable, or when individual control over doses is desired.
💡 Mechanism of Action:Tenofovir (TDF): A nucleotide reverse transcriptase inhibitor (NRTI)
Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI)
Efavirenz: A non-nucleoside reverse transcriptase inhibitor (NNRTI)
These three drugs block reverse transcriptase — an enzyme HIV needs to replicate.
📆 Dosage & Administration:1 kit daily (containing 2 tablets):
Take both tablets together at bedtime, ideally on an empty stomach to reduce CNS side effects from Efavirenz.
Complete triple-drug therapy in 1 kit
Good for settings where single-pill TLE is unavailable
Flexible in dose adjustments if needed
24 months from date of manufacture
Store below 30°C, keep in a dry place
Not recommended as first-line anymore in some countries (due to shift to Dolutegravir-based regimens like TLD)
Still widely used in many HIV programs
Effective and affordable therapy for viral load suppression
Additional Information:
View Complete details
Minimum Order Quantity: 10 Pack
| Strength | 150 mg |
| Packing Type | Bottle |
| Packaging Size | 60 Tablets |
| Brand | Lavir 150 Mg |
| Manufacturer | Emcure Pharma |
| Shelf Life | 36 months |
Generic Name: Lamivudine 150 mg
Manufacturer: Cipla Ltd
Class: NRTI – Nucleoside Reverse Transcriptase Inhibitor
Indications:
HIV-1 infection (as part of ART combination)
Chronic Hepatitis B (off-label in some cases)
Lavir 150 mg is a widely used antiretroviral medicine that contains Lamivudine, a key backbone drug in many first-line HIV regimens. It is usually prescribed with Zidovudine, Tenofovir, or Efavirenz.
It inhibits the reverse transcriptase enzyme, thereby preventing HIV from replicating in the body.
💡 Common Uses:ART (Antiretroviral Therapy) – used in fixed-dose combinations like TLE, Duovir, etc.
Sometimes used as a standalone or with Tenofovir in co-infected HIV-HBV patients
36 months from manufacturing
Store below 30°C, away from moisture
WHO-approved molecule
Highly effective, well tolerated
Foundational drug in HIV programs worldwide
Cost-effective and broadly available
Generic Name: Lamivudine 100 mg
Manufacturer: Hetero Healthcare
Class: NRTI – Nucleoside Reverse Transcriptase Inhibitor
Indications:
Chronic Hepatitis B virus (HBV) infection
Heptavir 100 mg is used specifically for the management of chronic Hepatitis B, not HIV. It slows down viral replication and reduces liver inflammation and fibrosis progression.
Though it shares the same molecule (Lamivudine) as Lavir, it comes in a 100 mg dose, which is the standard for HBV monotherapy — not for HIV.
💡 Common Uses:Monotherapy for chronic Hepatitis B, especially in resource-limited settings
Alternative option if Tenofovir is contraindicated
24 to 36 months
Store at room temperature, under 30°C
Trusted option for HBV control
Usually replaced by Tenofovir due to higher HBV resistance with Lamivudine
Affordable and easy to use
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 60 Tablets |
| Composition | Lamivudine 150 mg + Nevirapine 200 mg + Stavudine 40 mg |
| Packaging Type | Bottle |
| Prescription/Non Prescription | Non Prescription |
| Country of Origin | Made in India |
Manufacturer: Hetero Healthcare Ltd
Type: Fixed-Dose Combination Antiretroviral (Triple Drug)
Drug Class: NRTIs + NNRTI
Formulation: Oral tablet
Stavudine – 40 mg
Lamivudine – 150 mg
Nevirapine – 200 mg
This fixed-dose combination is part of the first-generation ART regimens used in the management of HIV-1 infection.
📌 Description:Nevilast 40 mg is a triple combination antiretroviral tablet that combines:
Two NRTIs (Stavudine + Lamivudine): They work by mimicking natural nucleosides and blocking reverse transcriptase.
One NNRTI (Nevirapine): It binds directly to reverse transcriptase and inhibits its function.
Together, they inhibit viral replication and help control the HIV infection, reducing the viral load and improving immune function.
💡 Indications / Uses:Treatment of HIV-1 infection in adults and adolescents
Often prescribed in resource-limited settings
Used as part of combination ART
Typically one tablet twice daily, or as directed by a healthcare provider
Dosing must be adjusted in case of liver or kidney dysfunction
Nevirapine requires a lead-in period of 14 days (if starting freshly)
24 to 36 months from manufacturing date
Store below 30°C, in a cool, dry place
Typically available in:
30-tablet bottle
10-tablet strip
Color: Often white or off-white tablets
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Dose/Strength | 200 mg x 50 mg |
| Packaging Type | Box |
| Brand | Mylan |
| Manufacturer | Mylan |
| Shelf Life | 36 months |
Manufacturer: Hetero Healthcare Ltd
Formulation: Fixed-dose combination (FDC) tablet
Drug Class: Antiretroviral Therapy – NRTIs + NNRTI
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine (3TC) – 300 mg
Efavirenz (EFV) – 600 mg
Treatment of HIV-1 infection in adults and adolescents
Recommended as a first-line ART regimen by WHO
Effective in viral suppression and immune recovery
Tenofovir and Lamivudine: NRTIs that inhibit reverse transcriptase by causing DNA chain termination
Efavirenz: NNRTI that binds directly to reverse transcriptase and inhibits viral replication
One tablet once daily, preferably at bedtime
Can be taken with or without food, but taking with food may increase Efavirenz absorption
Manufacturer: Emcure Pharmaceuticals Ltd
Formulation: Fixed-dose combination tablet
Drug Class: NRTIs + NNRTI
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine (3TC) – 300 mg
Efavirenz (EFV) – 600 mg
HIV-1 infection treatment in adults and adolescents
WHO-recommended first-line ART regimen
Same as Alltera (NRTIs + NNRTI)
One tablet once daily at bedtime
May be taken with or without food
Manufacturer: Hetero Healthcare Ltd
Formulation: Fixed-dose combination tablet
Drug Class: NRTIs + NNRTI
Lamivudine (3TC) – 150 mg
Zidovudine (AZT) – 300 mg
Efavirenz (EFV) – 600 mg
Treatment of HIV-1 infection
Alternative regimen especially when Tenofovir is contraindicated or not tolerated
Zidovudine and Lamivudine inhibit reverse transcriptase (NRTIs)
Efavirenz inhibits reverse transcriptase (NNRTI)
One tablet twice daily or as prescribed
Food intake not critical, but consistent dosing recommended
Manufacturer: Hetero Healthcare Ltd
Formulation: Fixed-dose combination of Protease Inhibitors
Drug Class: Protease Inhibitors (PIs)
Lopinavir – 200 mg
Ritonavir – 50 mg
Second-line antiretroviral therapy for HIV-1 infection
Used in patients with resistance or failure of first-line ART regimens
Acts as a "booster" (Ritonavir boosts Lopinavir levels)
Both drugs inhibit HIV protease enzyme, preventing viral maturation
Ritonavir inhibits cytochrome P450 3A4 to increase Lopinavir plasma concentration
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 200 mg |
| Packaging Type | Bottle |
| Packaging Size | 60 Tablets |
| Brand | Nevimune 200 Mg |
| Manufacturer | Cipla |
| Shelf Life | 36 months |
Generic Name: Nevirapine
Manufacturer: Cipla Ltd
Drug Class: NNRTI (Non-Nucleoside Reverse Transcriptase Inhibitor)
Nevirapine – 200 mg
Used in combination with other antiretroviral agents for the treatment of HIV-1 infection
Also used to prevent mother-to-child transmission during childbirth in certain protocols
Nevirapine binds directly to reverse transcriptase, blocking the RNA-to-DNA conversion process essential for HIV replication.
💡 Dosage & Administration:Standard initiation: 200 mg once daily for 14 days (to reduce rash risk), then 200 mg twice daily
Must be used in combination therapy, not as monotherapy
Generic Name: Nevirapine
Manufacturer: Hetero Healthcare
Drug Class: NNRTI
Nevirapine – 200 mg
Same as Nevimune — for use in combination ART in HIV-1 infections
⚙️ Mechanism of Action:Inhibits reverse transcriptase by binding to an allosteric site and blocking viral DNA synthesis
💡 Dosage & Administration:Same as Nevimune — initiated at 200 mg once daily for 14 days, then increased to 200 mg twice daily
Always used in combination with other ART drugs
Generic Name: Nevirapine Extended Release
Manufacturer: Hetero Healthcare
Drug Class: NNRTI
Nevirapine – 400 mg (Extended Release)
For treatment of HIV-1 infection in patients who have tolerated 200 mg BID of immediate-release Nevirapine for at least 14 days
Provides once-daily convenience
Same as standard Nevirapine but formulated for extended release — maintains effective plasma levels for 24 hours
💡 Dosage & Administration:One tablet once daily after lead-in phase (initial 14 days on 200 mg IR Nevirapine BID)
Must be used with at least two other antiretroviral agents
Generic Name: Nevirapine
Manufacturer: Emcure Pharmaceuticals
Drug Class: NNRTI
Nevirapine – 200 mg
Part of combination therapy for HIV-1 infection
Inhibits reverse transcriptase — same as others
💡 Dosage & Administration:Start with 200 mg once daily for 14 days, then switch to 200 mg twice daily
Use as part of a combination antiretroviral regimen
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Dose Strength | 25 mg |
| Manufacture By | Cipla Ltd |
| Brand | Tenvir-AF |
| Packaging Size | 30 tablets |
| Packaging Type | Bottle |
Generic Name: Tenofovir Alafenamide (TAF)
Manufacturer: Cipla Ltd
Drug Class: NRTI (Nucleotide Reverse Transcriptase Inhibitor)
Tenofovir Alafenamide 25 mg
Used in the treatment of HIV-1 infection (as part of combination ART)
Treatment of chronic hepatitis B infection
TAF is a prodrug of tenofovir, which inhibits HIV reverse transcriptase by incorporating into viral DNA and causing chain termination. Compared to TDF (Tenofovir DF), it delivers higher intracellular levels of active drug with lower systemic toxicity.
💡 Dosage & Administration:Typically 1 tablet once daily with or without food
Must be part of a combination ART regimen
Generic Name: Tenofovir Alafenamide (TAF)
Manufacturer: Hetero Healthcare Ltd
Drug Class: NRTI
Tenofovir Alafenamide 25 mg
Treatment of HIV-1 and chronic HBV infections
Same as Tenvir AF — provides targeted intracellular action with lower plasma exposure, hence improved renal and bone safety profile
💡 Dosage & Administration:Once daily with or without food
Often used in combination packs or with Dolutegravir/Lamivudine
Generic Name: Tenofovir Alafenamide (TAF)
Manufacturer: Emcure Pharmaceuticals Ltd
Drug Class: NRTI
Tenofovir Alafenamide 25 mg
Used in HIV combination ART
Approved for chronic hepatitis B
Same as others — converts to active tenofovir diphosphate within cells, inhibiting reverse transcriptase.
💡 Dosage & Administration:1 tablet daily (in combo therapy)
Generic Name: Tenofovir Alafenamide (TAF)
Manufacturer: Zydus Lifesciences Ltd
Drug Class: NRTI
Tenofovir Alafenamide 25 mg
Primarily used in chronic Hepatitis B treatment
Also applicable for HIV-1 in combination with other antiretrovirals
Same as the others — inhibits reverse transcriptase; shows liver-focused delivery, making it more suitable for hepatitis B patients
💡 Dosage & Administration:Once daily orally, preferably as part of a structured regiment
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Brand | Cipla |
| Manufacturer | Cipla Ltd |
| Shelf Life | 36 months |
Generic Name: Tenofovir Disoproxil Fumarate (TDF)
Manufacturer: Cipla Ltd
Drug Class: NRTI (Nucleotide Reverse Transcriptase Inhibitor)
Tenofovir Disoproxil Fumarate – 300 mg
Treatment of HIV-1 infection (in combination with other antiretrovirals)
Treatment of chronic hepatitis B infection
Converted into tenofovir diphosphate inside cells → inhibits reverse transcriptase enzyme → halts viral replication.
�� Dosage:300 mg once daily, preferably with food
Always used as part of combination antiretroviral therapy
Generic Name: Tenofovir Disoproxil Fumarate
Manufacturer: Mylan/Viatris
Drug Class: NRTI
Tenofovir Disoproxil Fumarate – 300 mg
Used in HIV (as part of ART)
Also approved for chronic HBV
Same as above – inhibits reverse transcriptase by incorporating into viral DNA and causing chain termination
�� Dosage:300 mg once daily
Generic Name: Tenofovir Disoproxil Fumarate
Manufacturer: Hetero Healthcare
Drug Class: NRTI
Tenofovir Disoproxil Fumarate – 300 mg
HIV-1 infection as part of triple drug therapy
Chronic HBV infection
Inhibits viral replication by interfering with reverse transcriptase, stopping DNA elongation
�� Dosage:300 mg once daily
Generic Name: Tenofovir Disoproxil Fumarate
Manufacturer: Zydus Lifesciences Ltd
Drug Class: NRTI
Tenofovir Disoproxil Fumarate – 300 mg
Often prescribed for hepatitis B
Also used in HIV regimens
Same as others – blocks viral reverse transcriptase enzyme by mimicking natural nucleotides
�� Dosage:1 tablet daily (usually as part of a combination)
Additional Information:
View Complete details
Minimum Order Quantity: 10 Strip
| Packaging Size | 1*10 Tablets |
| Strength | 450 mg |
| Packaging Type | Stripe |
| Brand | Valcip 450 mg |
| Manufacturer | Cipla Ltd |
| Shelf Life | 24 months |
Generic Name: Valganciclovir Hydrochloride
Brand Name: Valcip
Manufacturer: Cipla Ltd
Strength: 450 mg
Drug Class: Antiviral (Guanine nucleoside analog)
Treatment of CMV retinitis in patients with AIDS
Prevention of CMV infection in organ transplant recipients
Valganciclovir is a prodrug of ganciclovir. Once converted, it:
Inhibits viral DNA polymerase
Gets incorporated into viral DNA → halts replication
CMV Retinitis (induction): 900 mg twice daily for 21 days
Maintenance / Prevention: 900 mg once daily
Renal dosing adjustments required
Neutropenia, anemia, thrombocytopenia
GI upset: nausea, vomiting, diarrhea
Headache, fatigue
Elevated liver enzymes (AST/ALT)
Most widely prescribed valganciclovir in India
WHO & national ART programs often list it
Generic Name: Valganciclovir Hydrochloride
Brand Name: CMVee
Manufacturer: Emcure Pharmaceuticals
Strength: 450 mg
Drug Class: Antiviral
CMV infections in immunocompromised adults
Post-transplant CMV prevention
Same as Valcip – converts to ganciclovir → stops viral DNA replication
💡 Dosage:Follows same protocol: 900 mg/day or 900 mg twice daily during induction
⚠️ Side Effects:Hematologic suppression (monitor blood counts)
GI disturbances
Rare: neurotoxicity in high doses
Common in institutional and hospital tenders
Cost-effective alternative
Generic Name: Valganciclovir Hydrochloride
Brand Name: Emval
Manufacturer: Macleods Pharmaceuticals
Strength: 450 mg
Drug Class: Antiviral (CMV-specific)
CMV retinitis in HIV patients
CMV prophylaxis post kidney, liver, heart transplants
Blocks CMV DNA polymerase by integrating false nucleotides → virus replication halts
💡 Dosage:900 mg/day or bid based on stage
Requires dose adjustment in kidney dysfunction
Bone marrow suppression
Headache, tremor
Liver function disturbance
Less common but effective option for CMV therapy
Sometimes preferred in non-branded tenders
Additional Information:
View Complete details
Minimum Order Quantity: 10 Strip
| Packaging Size | 5*2 Tablets |
| Strength | 450 mg |
| Packaging Type | Stripe |
| Brand | Valgacel 450 Mg Tablets |
| Manufacturer | Intas Pharma |
| Shelf Life | 24 months |
Generic Name: Valganciclovir Hydrochloride
Brand Name: Valgacel
Manufacturer: Glenmark Pharmaceuticals
Strength: 450 mg
Drug Class: Antiviral (Guanine nucleoside analog)
Treatment of CMV retinitis in AIDS patients
Prevention of CMV infection in organ transplant recipients
Prodrug converted to ganciclovir
Inhibits viral DNA polymerase, stopping viral DNA synthesis and replication
Induction: 900 mg twice daily for 21 days
Maintenance: 900 mg once daily
Requires dose adjustment in renal impairment
Bone marrow suppression (neutropenia, anemia)
Nausea, diarrhea, headache
Possible renal toxicity and liver enzyme elevation
Generic Name: Valganciclovir Hydrochloride
Brand Name: Cymgal
Manufacturer: Cadila Pharmaceuticals
Strength: 450 mg
Drug Class: Antiviral
CMV retinitis treatment in immunocompromised patients
Prophylaxis against CMV post-transplantation
Converts to ganciclovir intracellularly
Blocks viral DNA polymerase to inhibit CMV replication
Same as standard valganciclovir protocols
Renal function monitoring recommended
Hematologic effects like neutropenia
GI upset (nausea, vomiting)
Headache and fatigue
Generic Name: Valganciclovir Hydrochloride
Brand Name: Virolfi
Manufacturer: Lupin Pharmaceuticals
Strength: 450 mg
Drug Class: Antiviral
CMV retinitis in AIDS
CMV infection prophylaxis in transplant recipients
Prodrug of ganciclovir, inhibits viral DNA polymerase
Stops CMV replication effectively
Induction and maintenance dosing as per guidelines
Dose adjustment required for renal impairment
Bone marrow suppression (monitor CBC)
Gastrointestinal discomfort
Rare neurologic symptoms
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Strength | 300 mg |
| Packaging Type | Bottle |
| Brand | Zidine 300 Mg |
| Manufacturer | Emcure Pharma |
| Shelf Life | 36 months |
Generic Name: Zidovudine
Brand Name: Zidine
Strength: 300 mg
Manufacturer: (Varies by region; commonly available from multiple manufacturers)
Drug Class: Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor - NRTI)
Used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Prevention of mother-to-child transmission of HIV during pregnancy, labor, and delivery.
Post-exposure prophylaxis following potential HIV exposure.
Zidovudine is a nucleoside analogue that inhibits the activity of HIV reverse transcriptase.
It gets incorporated into viral DNA, causing premature termination of DNA chain elongation, thus preventing viral replication.
Typical adult dose: 300 mg orally twice daily.
Dosage adjustments may be necessary in patients with renal impairment.
Should always be used as part of a combination antiretroviral therapy (ART) regimen.
Zidovudine (Zidine) was the first approved antiretroviral drug and remains important in HIV treatment.
Monitoring blood counts regularly is essential due to risk of bone marrow suppression.
Usually combined with other antiretrovirals for optimal viral suppression.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Type | Bottle |
| Packaging Size | 30 Tablets |
| Brand | Abec L Tablets |
| Composition | ABACAVIR & LAMIVUDINE |
Composition:
Abacavir (ABC) – 600 mg
Lamivudine (3TC) – 300 mg
Drug Class: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Both Abacavir and Lamivudine inhibit the reverse transcriptase enzyme of HIV, preventing viral replication by blocking the conversion of viral RNA into DNA.
✅ Indications:Used in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Commonly included in first-line ART regimens, especially where Dolutegravir is added separately.
One tablet once daily, with or without food.
Often taken alongside a third drug like Dolutegravir or Efavirenz for complete therapy.
24–36 months from the date of manufacture.
Store below 30°C, away from moisture and heat.
Commonly manufactured by Emcure Pharmaceuticals and Hetero Healthcare in India.
Two essential NRTIs in a single pill, reducing pill burden.
Often used in resource-limited settings due to its cost-effectiveness.
Used when Inbec or Triumeq are not available or not suitable.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 30 tablets |
| Manufacture By | Emcure Pharma |
| Packaging Type | Bottle |
| Brand | Twinaqt Tablets |
Generic Name: Dolutegravir 50 mg + Lamivudine 300 mg
Manufacturer: Emcure Pharmaceuticals Ltd
Twinaqt is a fixed-dose combination antiretroviral used in the treatment of HIV-1 infection. It contains:
Dolutegravir (50 mg) – an integrase strand transfer inhibitor (INSTI)
Lamivudine (300 mg) – a nucleoside reverse transcriptase inhibitor (NRTI)
This combination offers a 2-drug regimen option for HIV-1 treatment, ideal for certain stable patients, particularly those who are already virally suppressed.
🧪 Composition (per tablet):Dolutegravir 50 mg
Lamivudine 300 mg
Treatment of HIV-1 infection in adults and adolescents weighing ≥35 kg
Usually prescribed as a maintenance regimen for patients who are already virologically suppressed and without history of resistance
One tablet once daily, with or without food
Should be taken regularly at the same time each day
Simplified 2-drug regimen for eligible patients
Less pill burden, improving patient adherence
Lower long-term toxicity (compared to 3-drug regimens in stable patients)
High resistance barrier due to Dolutegravir
24 months (2 years) from the date of manufacture
Store below 30°C, in a dry place away from sunlight and moisture
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Brand | Cipla |
| Manufacturer | Cipla Ltd |
| Shelf Life | 24 months |
Manufacturer: Cipla Ltd
Generic Composition:
Tenofovir Disoproxil Fumarate (TDF) 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
📌 Description:
Viraday is one of the most trusted and oldest brands of TLE (Tenofovir + Lamivudine + Efavirenz) used in the treatment of HIV-1 infection.
It is often used as a once-daily, single-pill regimen for adults and adolescents.
Viraday has strong international recognition and is widely prescribed for export as well as private-sector HIV therapy.
💡 Uses:
First-line antiretroviral therapy for HIV
Post-exposure prophylaxis (off-label)
📆 Dosage:
1 tablet once daily, preferably at bedtime (to reduce dizziness, vivid dreams)
💊 2. Vonavir Tablet
Manufacturer: Emcure Pharmaceuticals
Generic Composition:
Tenofovir Disoproxil Fumarate (TDF) 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
📌 Description:
Vonavir is a cost-effective Indian generic for the TLE regimen, used widely in government ART programs, low-cost hospitals, and by NGOs.
It offers equivalent efficacy to Viraday but at a more economical price point.
💡 Uses:
First-line HIV treatment
Substitution in patients already on TLE
📆 Dosage:
One tablet daily, ideally at night
Manufacturer: Hetero Healthcare
Generic Composition:
Tenofovir Disoproxil Fumarate (TDF) 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
📌 Description:
Teevir is a popular generic TLE formulation widely distributed through public-private partnerships, HIV screening camps, and district-level ART centers.
It balances cost with availability, making it a go-to in rural and semi-urban areas.
💡 Uses:
Management of HIV-1 infection
Works well as initial or continued ART
📆 Dosage:
1 tablet daily, bedtime preferred
💊 4. Trustiva Tablet
Manufacturer: Laurus Labs
Generic Composition:
Tenofovir Disoproxil Fumarate (TDF) 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
📌 Description:
Trustiva is a newer yet high-quality TLE product from Laurus Labs, a globally reputed API and formulation manufacturer.
It is WHO-GMP compliant and often used in international tenders and export markets.
It is gaining popularity due to its balance of price, quality, and availability.
💡 Uses:
Antiretroviral therapy for adults
Used in both national and international HIV programs
📆 Dosage:
One tablet daily, preferably at night
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Brand | Mylan |
| Manufacturer | Mylan Pharma |
| Shelf Life | 24 months |
Manufacturer: Hetero Healthcare
Drug Class: Fixed-dose combination antiretroviral therapy
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine – 300 mg
Efavirenz – 600 mg
📌 Description:
Vonaday is a once-daily antiretroviral used in the treatment of HIV-1 infection in adults. It is part of India's national ART program and is also prescribed in the private sector due to its balance of cost and quality. Produced by Hetero, one of India's largest ARV suppliers, it is considered a standard TLE brand.
📆 Dosage:
1 tablet at bedtime daily, ideally on an empty stomach to reduce CNS side effects from Efavirenz.
💡 Uses:
First-line HIV therapy
Effective in viral suppression
Also used in post-exposure prophylaxis (PEP) (off-label)
Manufacturer: Mylan (Viatris)
Drug Class: Antiretroviral (TLE) combination
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine – 300 mg
Efavirenz – 600 mg
📌 Description:
Telura is one of the most internationally trusted TLE tablets. Manufactured by Mylan, now part of Viatris, it's used extensively in PEPFAR, UN programs, and international HIV treatment programs. Known for stringent quality standards, Telura is WHO-prequalified and widely exported.
📆 Dosage:
Take 1 tablet once daily, preferably at bedtime.
💡 Uses:
Long-term HIV treatment
Used in both public health and private clinics globally
💊 3. Vianca Tablet
Manufacturer: Strides Pharma
Drug Class: Antiretroviral therapy
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine – 300 mg
Efavirenz – 600 mg
📌 Description:
Vianca is a generic fixed-dose TLE tablet formulated by Strides, known for supplying generic ARVs to many parts of Africa and Asia. It is cost-effective, with moderate use in India and growing presence in export markets.
📆 Dosage:
1 tablet daily, preferably at bedtime.
💡 Uses:
HIV-1 treatment
Can be considered in resource-limited settings
💊 4. Tenolam E Tablet
Manufacturer: Hetero Healthcare
Drug Class: TLE (Triple drug combination)
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Lamivudine – 300 mg
Efavirenz – 600 mg
📌 Description:
Tenolam E is another TLE combination from Hetero, mainly intended for hospital and pharmacy supply at a budget-friendly rate. It is essentially an alternate branding of Vonaday with similar content but used in bulk procurement and stock substitution.
📆 Dosage:
1 tablet once a day at night
💡 Uses:
Effective for HIV-1 suppression
Works identically to other TLE options
Additional Information:
View Complete details
Minimum Order Quantity: 10 Strip
| Packing Type | Blister |
| Brand | Duovir-E Kit |
| Manufacturer | Cipla Ltd |
| Shelf Life | 24 months |
Manufacturer: Cipla Ltd
Drug Class: Antiretroviral Combination Therapy (Kit)
Indication: Treatment of HIV-1 infection
Each Duovir-E Kit contains:
1 tablet of Efavirenz 600 mg
1 tablet of Lamivudine 150 mg + Zidovudine 300 mg
These are taken together once daily — typically at bedtime.
📌 Description:Duovir-E Kit is a widely trusted first-line antiretroviral therapy by Cipla, combining three potent HIV medications into a two-pill kit. It is especially useful where fixed-dose triple combinations are not feasible or in resource-limited settings.
Cipla’s brand is widely used in India, Africa, and parts of Southeast Asia due to strong distribution and inclusion in national ART programs.
💡 Mechanism of Action:Efavirenz – NNRTI: blocks reverse transcriptase
Lamivudine + Zidovudine – NRTIs: inhibit viral DNA synthesis
Together, they suppress HIV replication and reduce viral load.
📆 Dosage:Take both tablets once daily, preferably at bedtime on an empty stomach (to minimize Efavirenz-related CNS effects)
24 months from manufacturing
Store in a cool, dry place below 30°C
Cipla’s quality & trust
WHO-GMP compliant
Often supplied via NGOs & public tenders
Strong track record in viral suppression
Manufacturer: Hetero Healthcare
Drug Class: Antiretroviral Combination Therapy (Kit)
Indication: HIV-1 infection management
Each Lazid-E Kit includes:
1 tablet of Efavirenz 600 mg
1 tablet of Lamivudine 150 mg + Zidovudine 300 mg
Same regimen as Duovir-E, taken together once daily.
📌 Description:Lazid-E Kit by Hetero is a cost-effective ARV kit, used in first-line HIV treatment regimens. It contains the same WHO-recommended drugs as Duovir-E and is manufactured under stringent GMP conditions.
While not as widely used as Cipla's kit, it is still trusted in many private setups and tenders, especially where affordability is key.
💡 Mechanism of Action:Same as Duovir-E — triple ARV combination working synergistically to inhibit HIV replication.
📆 Dosage:Take both tablets once daily, ideally at night
Can be taken with water, on an empty stomach
24 months
Store below 30°C
Budget-friendly option
WHO-GMP certified by Hetero
Reliable alternate to Duovir-E
Flexible use in institutions and low-cost programs
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Manufacture By | Hetero Healthcare |
| Brand | Tenof-EM Tablets |
| Packaging Size | 30 tablets |
| Packaging Type | Bottle |
Manufacturer: Hetero Healthcare
Drug Type: TDF-based ART / PrEP
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Emtricitabine – 200 mg
Tenof-EM is one of the most widely used Tenofovir + Emtricitabine combinations in HIV treatment and prevention (PrEP). Manufactured by Hetero, it’s part of national and global HIV programs, including PEPFAR and NACO India.
💡 Uses:HIV-1 treatment (part of triple therapy)
PrEP (Pre-Exposure Prophylaxis)
PEP (Post-Exposure Prophylaxis) (with other drugs)
24 to 36 months
Manufacturer: Hetero Healthcare
Drug Type: TAF-based ART / PrEP
Composition:
Tenofovir Alafenamide (TAF) – 25 mg
Emtricitabine – 200 mg
Tafero-EM is a new-generation HIV medication that uses TAF, a safer prodrug of Tenofovir. It achieves high antiviral activity at a lower dose, reducing risk to kidneys and bones.
It is increasingly used for long-term treatment and is part of modern PrEP protocols in some countries.
💡 Uses:Long-term HIV-1 treatment
PrEP (preferred for patients with renal risk)
24 months
Manufacturer: Emcure Pharmaceuticals
Drug Type: TDF-based ART / PrEP
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Emtricitabine – 200 mg
Tavin-EM is a generic Tenofovir-Emtricitabine tablet produced by Emcure. It is used in both treatment regimens and prevention protocols like PrEP or PEP, mostly in India and a few export markets.
Not as widely used as Tenof-EM but still recognized for quality.
💡 Uses:HIV treatment (triple therapy)
PrEP and PEP regiment
Manufacturer: Mylan (now part of Viatris)
Drug Type: TAF-based ART / PrEP
Composition:
Tenofovir Alafenamide (TAF) – 25 mg
Emtricitabine – 200 mg
Taficita is a premium quality TAF-based tablet, WHO-prequalified and exported globally. Often used in combination with Dolutegravir (as part of TLD or TAF-based ART regimens).
Preferred where quality assurance and international compliance are required.
💡 Uses:HIV treatment
PrEP (especially for at-risk individuals with renal issues)
Manufacturer: Cipla
Drug Type: TDF-based ART
Composition:
Tenofovir Disoproxil Fumarate (TDF) – 300 mg
Emtricitabine – 200 mg
Emtaf by Cipla is a reliable TDF-based combination, part of the company’s long-standing HIV portfolio. It is used in combination therapies and for PrEP in select protocols. Its usage is moderate, less than Tenof-EM.
💡 Uses:First-line HIV therapy
PrEP/PEP in selected contexts
Additional Information:
View Complete details
Minimum Order Quantity: 10 Strip
| Packing Type | Blister |
| Packaging Size | 30 Tablets |
| Brand | Tavin LN Kit |
| Manufacturer | Emcure |
| Shelf Life | 36 months |
Brand: Tavin LN Kit
Manufacturer: Emcure Pharmaceuticals Ltd
Formulation: Oral Fixed-Dose Combination Therapy
Therapeutic Class: Antiretroviral (ARV) – NRTIs + NNRTI
Use: HIV-1 infection treatment
Each daily kit typically includes:
Tenofovir Disoproxil Fumarate – 300 mg
Lamivudine – 300 mg
Nevirapine – 200 mg
These three drugs act synergistically to suppress HIV replication and reduce viral load in patients.
📌 Indications / Uses:First-line treatment of HIV-1 infection in adults and adolescents
Especially common in resource-limited settings
Part of Highly Active Antiretroviral Therapy (HAART)
Tenofovir and Lamivudine: Nucleoside Reverse Transcriptase Inhibitors (NRTIs) – block reverse transcriptase, halting virus replication
Nevirapine: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) – binds directly to reverse transcriptase and inhibits enzyme activity
Together, the combination helps:
Lower viral load
Increase CD4+ T-cell counts
Delay HIV progression
One full kit (3 tablets) once daily, or as advised by the doctor
Nevirapine lead-in phase: often started with a lower dose of Nevirapine (e.g., 200 mg once daily for 14 days) to reduce risk of rash or liver toxicity
Tablets can be taken with or without food, preferably at the same time each day
Store below 30°C, in a cool and dry place
Protect from moisture and direct sunlight
Shelf life: Around 24 to 36 months from manufacturing date
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packing Type | Bottle |
| Packaging Size | 30 Tablets |
| Brand | Duovir-N Tablets |
| Manufacturer | Cipla Ltd |
| Shelf Life | 24 months |
Manufacturer: Cipla Ltd
Formulation: Fixed-dose combination (Triple drug)
Drug Class: NRTIs + NNRTI
Lamivudine – 150 mg
Zidovudine – 300 mg
Nevirapine – 200 mg
Treatment of HIV-1 infection in adults and adolescents
Used as part of first-line antiretroviral therapy (ART)
Lamivudine & Zidovudine: Nucleoside Reverse Transcriptase Inhibitors (NRTIs) – inhibit viral DNA synthesis
Nevirapine: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) – binds reverse transcriptase directly
Typically one tablet twice daily, or as prescribed
Nevirapine requires a lead-in period (usually 14 days at a lower dose)
Manufacturer: Hetero Healthcare Ltd
Formulation: Triple drug fixed-dose combination
Drug Class: NRTIs + NNRTI
Lamivudine – 150 mg
Zidovudine – 300 mg
Nevirapine – 200 mg
HIV-1 infection in treatment-naive patients or as part of combination ART
One tablet twice daily, post Nevirapine initiation with a lead-in period
Should be taken consistently at the same time each day
Manufacturer: Emcure Pharmaceuticals Ltd
Formulation: Fixed-dose triple combination
Drug Class: NRTIs + NNRTI
Lamivudine – 150 mg
Zidovudine – 300 mg
Nevirapine – 200 mg
Treatment of HIV-1 as part of combination ART
Suitable for adult patients
Twice daily dosing, with appropriate lead-in for Nevirapine
Usually taken regardless of meals, with water
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Manufacturer | Emcure Pharma |
| Shelf Life | 36 months |
Manufacturer: Emcure Pharmaceuticals Ltd
Formulation: Fixed-dose combination oral tablet
Drug Class: Antiretroviral Therapy (ART) – Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Tenofovir Disoproxil Fumarate (TDF): 300 mg
Lamivudine (3TC): 300 mg
Treatment of HIV-1 infection in adults and adolescents
Used as part of first-line combination antiretroviral therapy (ART)
Suitable for patients requiring dual NRTI backbone therapy
Tenofovir and Lamivudine are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).
They inhibit the HIV reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA, which blocks viral replication.
Typically, one tablet taken once daily, or as prescribed by a healthcare professional.
Can be taken with or without food.
Adherence to dosing schedule is critical for efficacy and to prevent resistance.
Store in a cool, dry place below 30°C.
Keep away from direct sunlight and moisture.
Keep out of reach of children.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packing Type | Bottle |
| Packaging Size | 60 Tablets |
| Brand | Duovir Tablets |
| Manufacturer | Cipla ltd |
| Shelf Life | 36 months |
Manufacturer: Cipla Ltd
Formulation: Fixed-dose combination tablet
Drug Class: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Lamivudine (3TC): 150 mg
Zidovudine (AZT): 300 mg
Treatment of HIV-1 infection in adults and adolescents
Used as part of combination antiretroviral therapy (ART)
Effective in reducing viral load and improving immune function
Both drugs inhibit reverse transcriptase, an enzyme essential for HIV replication.
Lamivudine and Zidovudine act as nucleoside analogues that get incorporated into viral DNA and cause chain termination.
Typically, one tablet twice daily or as directed by a physician.
Can be taken with or without food.
Adherence to prescribed regimen is critical.
Common: headache, nausea, fatigue, anemia (due to zidovudine), gastrointestinal discomfort
Rare: neutropenia, liver enzyme elevation, hypersensitivity reactions
Manufacturer: Hetero Healthcare Ltd
Formulation: Fixed-dose combination tablet
Drug Class: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Lamivudine (3TC): 150 mg
Zidovudine (AZT): 300 mg
HIV-1 infection treatment in adults and adolescents
Part of antiretroviral therapy (ART) regimens
Helps decrease viral load and increase CD4+ cell count
Lamivudine and Zidovudine block reverse transcriptase activity, preventing HIV replication and infection spread.
Generally one tablet twice daily, or as prescribed.
May be taken with or without meals.
Consistency in timing enhances effectiveness.
Additional Information:
View Complete details
| Strength | 0.5 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strips |
| Also gives | Third Party Manufacturing |
| Country of Origin | Made in India |
View Complete details
Minimum Order Quantity: 10 Box
| Packaging Type | Blister |
| Manufacturer | Emcure Pharma |
| Shelf Life | 24 months |
Contents (Fixed-Dose Combination):
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
Description:
Reatix Kit is an antiretroviral medication used for the treatment of HIV-1 infection in adults and adolescents. It contains a triple combination of drugs in a single dose, simplifying therapy. The combination inhibits the reverse transcriptase enzyme, preventing the replication of HIV.
Tenofovir: A nucleotide reverse transcriptase inhibitor (NRTI)
Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI)
Efavirenz: A non-nucleoside reverse transcriptase inhibitor (NNRTI)
Administration:
One tablet daily, preferably at bedtime to reduce side effects.
Common Side Effects:
Dizziness, insomnia, vivid dreams, fatigue, rash.
Shelf Life:
24 to 36 months, depending on the batch and manufacturer.
Contents:
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Efavirenz 600 mg
Description:
Viro 4 Kit contains the same combination as Reatix and is also used as first-line therapy in HIV treatment. It is typically manufactured by different pharmaceutical companies and may be preferred where price or brand availability is a factor.
Mechanism:
Inhibits HIV replication by targeting different stages of reverse transcription.
Administration:
Once daily, preferably at night.
Side Effects:
Similar to Reatix: CNS effects (like sleep disturbances), rash, fatigue.
Shelf Life:
24 to 36 months
Contents:
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Atazanavir 300 mg
Ritonavir 100 mg
Description:
Tenolam AR Kit is used for second-line HIV treatment, typically when patients show resistance to first-line drugs like Efavirenz. The addition of Atazanavir (a protease inhibitor) and Ritonavir (a booster) enhances the antiretroviral activity by targeting a different step in the HIV life cycle.
Ritonavir boosts Atazanavir levels by inhibiting its metabolism.
Suitable for patients who have experienced Efavirenz toxicity or resistance.
Administration:
Usually once daily with food to improve absorption.
Common Side Effects:
Jaundice (bilirubin increase), GI upset, lipid changes, nausea.
Shelf Life:
24 months typically
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Manufacturer | Hetero Healthcare |
| Shelf Life | 24 months |
Manufacturer: Hetero Healthcare
Composition: Fixed-dose combination of three antiretroviral agents:
Tenofovir Alafenamide (TAF) 25 mg
Emtricitabine (FTC) 200 mg
Dolutegravir (DTG) 50 mg
Taffic is a once-daily, single-tablet regimen for the treatment of HIV-1 infection. It combines:
Tenofovir Alafenamide (TAF) – a nucleotide reverse transcriptase inhibitor (NRTI), with improved renal and bone safety compared to TDF.
Emtricitabine (FTC) – a potent NRTI that blocks HIV replication.
Dolutegravir (DTG) – an integrase strand transfer inhibitor (INSTI) that prevents HIV from integrating into the host DNA.
First-line treatment for HIV-1 in adults and adolescents weighing ≥35 kg.
Used either in ART-naïve patients or as a switch therapy for those virologically suppressed.
One tablet daily, with or without food.
Should be taken at the same time every day.
Monitor liver function in patients with hepatitis co-infection.
Not recommended for patients with known resistance to integrase inhibitors.
Assess renal function before and during treatment.
24 months from date of manufacture if stored properly below 30°C.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Manufacturer | Emcure Pharna |
| Shelf Life | 24 months |
Generic Name: Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide (TAF) 25 mg
Manufacturer: Emcure Pharmaceuticals Ltd
📌 Description:
Spegra is a fixed-dose combination antiretroviral therapy (ART) tablet used for the treatment of HIV-1 infection. It combines three potent agents from two classes:
Dolutegravir (INSTI) – blocks HIV integrase enzyme to prevent viral replication
Emtricitabine (NRTI) – inhibits reverse transcriptase enzyme
Tenofovir Alafenamide (NRTI) – newer, safer prodrug form of tenofovir, with better kidney and bone safety than TDF
It is designed as a once-daily single-pill regimen to simplify HIV treatment and improve adherence.
🧪 Composition (per tablet):
Dolutegravir: 50 mg
Emtricitabine: 200 mg
Tenofovir Alafenamide (TAF): 25 mg
💡 Indication / Uses:
First-line therapy for treatment-naive adults and adolescents with HIV-1 infection
Can be used as maintenance therapy in virologically suppressed patients when switching from another ART regimen
📆 Dosage:
One tablet once daily, with or without food
Must be taken exactly as prescribed to prevent resistance
Additional Information:
View Complete details
Minimum Order Quantity: 10 Bottle
| Packaging Size | 1x30Tablets |
| Manufacturer | Natco Pharma |
| Shelf Life | 24 months |
Generic Name: Lamivudine 300 mg + Tenofovir Disoproxil Fumarate (TDF) 300 mg + Dolutegravir 50 mg
Manufacturer: Emcure Pharmaceuticals
📌 Description:
Xapavir LT is a fixed-dose combination antiretroviral tablet, representing a TLD regimen, recommended as first-line therapy for HIV-1 infection.
Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI)
Tenofovir Disoproxil Fumarate (TDF): Another NRTI
Dolutegravir: An integrase strand transfer inhibitor (INSTI)
This triple combination blocks viral replication and strengthens the immune system.
🧪 Composition:
Lamivudine 300 mg
Tenofovir Disoproxil Fumarate 300 mg
Dolutegravir 50 mg
💡 Uses:
First-line treatment of HIV-1 infection
Suitable for adults and adolescents weighing ≥35 kg
📆 Dosage:
1 tablet once daily, with or without food
🗓️ Shelf Life:
24 months from manufacture
Generic Name: Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg
Manufacturer: Mylan (Viatris)
📌 Description:
Acriptega is a globally trusted single-tablet regimen (STR) for HIV-1 treatment, containing the WHO-recommended TLD components.
It is widely used in international HIV programs for its high quality and consistent availability.
🧪 Composition:
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Dolutegravir 50 mg
💡 Uses:
First-line and maintenance therapy for HIV-1 infection
Used across global programs like PEPFAR, Global Fund
📆 Dosage:
1 tablet once daily
🗓️ Shelf Life:
24 months to 36 months (check pack)
🌍 Trusted Worldwide:
WHO prequalified
Used in over 100 countries
High production standards
Generic Name: Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg
Manufacturer: Hetero Healthcare
📌 Description:
Viropil is another widely used TLD-based triple drug combination, known for its cost-effectiveness and availability in Indian and regional markets.
It is a go-to ART for many doctors in India due to its proven efficacy and affordability.
🧪 Composition:
Tenofovir Disoproxil Fumarate 300 mg
Lamivudine 300 mg
Dolutegravir 50 mg
💡 Uses:
First-line treatment for HIV-1 infection
Can be continued long-term if well tolerated
📆 Dosage:
One tablet daily, with or without food
🗓️ Shelf Life:
24 months from manufacture
Additional Information:
View Complete details
| Strength | 100 mg |
| Packing Type | Strip |
| Packaging Size | 1*10 Tablets |
| Brand | cipla |
| Usage / Application | Clinical |
Brand Name: | Lamivir 150mg |
Generic Name: | Lamivudine 150mg |
Company: | Cipla |
Strength: | 150MG |
packing: | 1x10 |
Type: | TAB |
Uses: | HIV |
View Complete details
| Dose/Strength | 250 mg |
| Form | Tablet |
| Usage/Application | Clinic |
| Brand | Natco |
| Packaging Type | Box |
View Complete details
Brand Name: | Abamune 300 MG |
Generic Name: | Abacavir 300 MG |
Company: | CIPLA |
Strength: | 300 MG |
packing: | 1X30 |
Type: | TABLET |
Uses: | ANTI HIV |
Some medical conditions may interact with Abamune (Abacavir). Tell your physician or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some medicines may interact with Abamune (Abacavir) . Tell your physician if you are taking any other medicines, especially any of the following:
View Complete details
| SKU | MM87 |
|---|---|
| Best_Value | N/A |
| US Brand Name | |
| Strength | 300mg |
| Generic Name | Tenofovir |
| Pharmaceutical Form | Tablet/s |
| Per Unit Pharmaceutical Form | Tablet |
| Manufacturer | Cipla, India |
| Shipped From | India |
View Complete details
Brand Name: | Duonase nasal spray |
Generic Name: | Azelastine 140mcg+fluticasone 50mcg |
Company: | Cipla |
packing: | 100 md |
Type: | Nasal spray |
Uses: | Asthama |
View Complete details
Brand Name: | Nelvir tab |
Generic Name: | Nelfinavir 250mg |
Company: | Cipla |
Strength: | 250mg |
packing: | 1x100 |
Type: | Tab |
Uses: | HIV |
View Complete details
Compositions:
Brand Name: | Adesera 10 MG |
Generic Name: | Adefovir dipivoxil 10 mg |
Company: | CIPLA |
Strength: | 10 mg |
packing: | 1X30 |
Type: | Tablets |
Uses: | Hepatitis B |
View Complete details